173 related articles for article (PubMed ID: 38393424)
21. ASPSCR1-TFE3 fusion in a case of Xp11 translocation PEComa of the liver: are ASPSCR1-TFE3 fusion-bearing tumours Xp11 translocation PEComa or alveolar soft part sarcoma?
Chai J; Ma J; Liu Y; Zhao D; Yin Z; Wang Z; Fan L
Pathology; 2023 Apr; 55(3):416-419. PubMed ID: 36104270
[No Abstract] [Full Text] [Related]
22. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
[TBL] [Abstract][Full Text] [Related]
23. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.
Aulmann S; Longerich T; Schirmacher P; Mechtersheimer G; Penzel R
Histopathology; 2007 Jun; 50(7):881-6. PubMed ID: 17543078
[TBL] [Abstract][Full Text] [Related]
24. Gene of the month: TFE 3.
Pinto K; Chetty R
J Clin Pathol; 2020 Nov; 73(11):691-694. PubMed ID: 32820043
[TBL] [Abstract][Full Text] [Related]
25. Revisiting cytomorphology, including unusual features and clinical scenarios of 8 cases of alveolar soft part sarcoma with TFE3 immunohistochemical staining in 7 cases.
Rekhi B; Rao V; Ramadwar M
Cytopathology; 2021 Jan; 32(1):20-28. PubMed ID: 32853443
[TBL] [Abstract][Full Text] [Related]
26. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma.
Tanaka M; Chuaychob S; Homme M; Yamazaki Y; Lyu R; Yamashita K; Ae K; Matsumoto S; Kumegawa K; Maruyama R; Qu W; Miyagi Y; Yokokawa R; Nakamura T
Nat Commun; 2023 Apr; 14(1):1957. PubMed ID: 37029109
[TBL] [Abstract][Full Text] [Related]
27. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
[TBL] [Abstract][Full Text] [Related]
28. Alveolar Soft Part Sarcoma.
Jaber OI; Kirby PA
Arch Pathol Lab Med; 2015 Nov; 139(11):1459-62. PubMed ID: 26516944
[TBL] [Abstract][Full Text] [Related]
29. Lingual Alveolar Soft Part Sarcoma in a 1-Year-Old Infant: Youngest Reported Case With Characteristic ASPSCR1-TFE3 Fusion.
Ruffle A; Cameron M; Jonas N; Levine S; Mills C; Hook CE; Murray MJ
Pediatr Dev Pathol; 2019; 22(4):391-395. PubMed ID: 30744536
[TBL] [Abstract][Full Text] [Related]
30. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.
Lazar AJ; Das P; Tuvin D; Korchin B; Zhu Q; Jin Z; Warneke CL; Zhang PS; Hernandez V; Lopez-Terrada D; Pisters PW; Pollock RE; Lev D
Clin Cancer Res; 2007 Dec; 13(24):7314-21. PubMed ID: 18094412
[TBL] [Abstract][Full Text] [Related]
31. Primary Thyroid Gland Alveolar Soft Part Sarcoma.
Whaley RD; Thompson LDR
Head Neck Pathol; 2020 Sep; 14(3):701-706. PubMed ID: 31782115
[TBL] [Abstract][Full Text] [Related]
32. Primary Alveolar Soft-Part Sarcoma of the Lung: A Case Report.
Zhao J; Peng J; Liu J; Deng Q; Pang X
Int J Surg Pathol; 2023 Feb; 31(1):98-103. PubMed ID: 35521911
[TBL] [Abstract][Full Text] [Related]
33. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
[TBL] [Abstract][Full Text] [Related]
34. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein.
Kobos R; Nagai M; Tsuda M; Merl MY; Saito T; Laé M; Mo Q; Olshen A; Lianoglou S; Leslie C; Ostrovnaya I; Antczak C; Djaballah H; Ladanyi M
J Pathol; 2013 Apr; 229(5):743-754. PubMed ID: 23288701
[TBL] [Abstract][Full Text] [Related]
35. Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
Lee CJ; Modave E; Boeckx B; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628499
[TBL] [Abstract][Full Text] [Related]
36. Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification.
Wang XT; Fang R; Zhang RS; Ye SB; Li R; Wang X; Pan R; Liu C; Chen JY; Zhao M; Teng XD; Yu WJ; Li YJ; Wang FH; Zhang JG; Yang QC; Zhang YS; Lu ZF; Ma HH; Zhou XJ; Xia QY; Rao Q
J Pathol; 2020 Aug; 251(4):365-377. PubMed ID: 32418203
[TBL] [Abstract][Full Text] [Related]
37. Meningeal alveolar soft part sarcoma confirmed by characteristic ASPCR1-TFE3 fusion.
Bodi I; Gonzalez D; Epaliyange P; Gullan R; Fisher C
Neuropathology; 2009 Aug; 29(4):460-5. PubMed ID: 18713311
[TBL] [Abstract][Full Text] [Related]
38. TFE3 immunoreactivity in alveolar soft part sarcoma of the uterine cervix: case report.
Roma AA; Yang B; Senior ME; Goldblum JR
Int J Gynecol Pathol; 2005 Apr; 24(2):131-5. PubMed ID: 15782069
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study.
Sharain RF; Gown AM; Greipp PT; Folpe AL
Hum Pathol; 2019 May; 87():65-74. PubMed ID: 30851332
[TBL] [Abstract][Full Text] [Related]
40. ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma.
Kenney S; Vistica DT; Stockwin LH; Burkett S; Hollingshead MG; Borgel SD; Butcher DO; Schrump DS; Shoemaker RH
J Pediatr Hematol Oncol; 2011 Jul; 33(5):360-8. PubMed ID: 21552147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]